Has Mohammad Burney, MD received payments from drug or device companies?

Yes. Drug and device makers reported $78,682 in general payments to Mohammad Burney, MD across 148 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mohammad Burney, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mohammad Burney, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mohammad Burney, MD

Orthopaedic Surgery · Rockwall, TXNPI 1932131398

Payments from drug & device makers

$78,682in general payments, 2019–2025

Across 148 payments — averaging $531.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Smith+Nephew$54K
Medical Device Business Services, Inc.$13K
Pylant Medical$3K
Zimmer Biomet$3K
Stryker$1K
Miach Orthopaedics, Inc.$1K
plus $4K from 14 others

$25,127in research payments, 2019–2025

Across 9 payments — averaging $2791.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Episurf Medical, Inc.$25K

What the payments were for

Consulting fees$1,2006%
Speaking & faculty fees$2,61013%
Travel & lodging$10,23250%
Food & beverage$5,10925%
Education$1,2276%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Smith+Nephew	38	$53,650
Medical Device Business Services, Inc.	5	$13,229
Pylant Medical	8	$2,670
Zimmer Biomet	23	$2,540
Stryker	12	$1,426
Miach Orthopaedics, Inc.	2	$1,367
Acelrx Pharmaceuticals, Inc.	7	$1,268
Arthrex	20	$1,210
Total Joint Orthopedics, Inc.	4	$398
Johnson & Johnson(2 entities)	6	$216
Orthalign Inc	3	$205
Bioventus LLC	9	$199
Abbott	2	$107
Integra Lifesciences Corporation	2	$60
Pacira Pharmaceuticals Incorporated	2	$39
Acumed LLC	1	$28
Osteocentric Technologies, Inc.	1	$25
Encore Medical, LP	1	$21
Orthofix Medical, Inc.	1	$14
Trice Medical, Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Q-FIX$7,378
Healicoil$4,537
MICRORAPTOR$2,550
Bone Anchors with Arthroscopic Delivery System$1,842
Ultrabraid$1,275
DSUVIA$1,200
MAKO$1,103
Juggerknot$1,083
Hips Product Portfolio$981
The Pink Hip Kit - Smith & Nephew Table$950
Bioraptor Knotless$734
SPEEDLOCK HIP$734
ACCUPASS DIRECT Crescent XL$734
Suturefix$734
CAP-FIX$284
HIPMAP$159
Speedlock$150
ORTHALIGN PLUS$141
Regeneten$124
Hipstruments$107

How this compares

$78,682 in reported general payments places this provider in the 90th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$576,871

Medicare patients

808

Services billed

16,299

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	524	$7,418
Celecoxib	31	$539
Acetaminophen-CodeineAcetaminophen With Codeine	41	$407
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	30	$363
Tramadol Hcl	50	$250
Diclofenac Sodium	35	$150
Gabapentin	15	$123
Ondansetron OdtOndansetron	11	$117
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	26	$93
Meloxicam	15	$30
Amoxicillin	16	$22

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Rockwall

Stephen BurkhartSan Antonio$185.3M
Kirby HittTemple$9.1M
J Richard EvansonPlano$8.1M
Stefan KreuzerHouston$7M
Robert GrahamAustin$6.3M
Richard JonesDallas$6.3M
Howard HarrisBedford$4.6M
Tiffany HuynhHouston$4.6M
Michael WirthSan Antonio$4.5M
Stephen IncavoHouston$4.3M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →